Endo Pharmaceuticals

Related News »
CHADDS FORD, Pa., May 25, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the Goldman Sachs 33rd Annual Global ...
May 24, 2012 at 23:57 | Source: 4-traders (press release)
CHADDS FORD, Pa., May 25, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the Jefferies 2012 Global Healthcare Conference on Monday, June 4 ...
May 24, 2012 at 23:57 | Source: 4-traders (press release)
When Endo Pharmaceuticals (NASDAQ:ENDP) reported earnings 17 days ago on May 1st, 2012, analysts, on average, expected the company to report earnings of $0.87 on sales of $703.9 million. Endo Pharmaceuticals actually reported earnings of $0.87 per share on ...
May 18, 2012 at 20:08 | Source: Financial News Network Online
May 24, 2012 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Pharmaceuticals industry with the lowest forward price to earnings (P/E) ratios. Forward P/E uses estimated earnings to compare relative value among ...
May 24, 2012 at 10:43 | Source: TMCnet
CHADDS FORD, Pa., May 23, 2012 /PRNewswire-FirstCall/ -- Shareholders of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) voted today at its annual shareholders meeting to approve changing the company's name to Endo Health Solutions Inc. 
May 23, 2012 at 15:59 | Source: TheStreet.com
New York, May 17th (TradersHuddle.com) - Shares of Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) ended the trading session higher by $0.64 or 1.94% from its previous close. Endo's price action formed what is considered to be a bullish engulfing candle ...
May 17, 2012 at 08:21 | Source: TradersHuddle.com
Endo Health Solutions Inc shares are currently trading ... ENDP makes up 3.64% of the SPDR S&P Pharmaceuticals ETF (AMEX: XPH)which is trading higher by about 0.5% on the day Friday.
May 25, 2012 at 20:21 | Source: Forbes
Noven’s lidocaine topical patch 5% is a generic version of Endo Pharmaceuticals’ Lidoderm ®. On May 15, 2012, pursuant to the Hatch-Waxman Act, Noven notified Endo and its partners (Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA ...
May 21, 2012 at 20:47 | Source: Miami Herald
Endo refers to these non-GAAP financial measures in making operating decisions because it believes they provide meaningful supplemental information regarding the company's operational performance. For instance, Endo believes that these non-GAAP financial ...
May 23, 2012 at 17:46 | Source: Yahoo! Finance
Through our operating companies: AMS, Endo Pharmaceuticals, HealthTronics and Qualitest, Endo is dedicated to improving care through a combination of branded products, generics, devices, technology and services that creates maximum value for ...
May 25, 2012 at 16:54 | Source: Yahoo Finance